Phase 3 Iron-Deficiency Anemia Clinical Trials
3 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects
Iron-Deficiency Anemia
AMAG Pharmaceuticals, Inc.75 enrolled15 locationsNCT03893045
Recruiting
Phase 3
Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient
Iron-Deficiency Anemia
Auerbach Hematology Oncology Associates P C104 enrolled1 locationNCT04268849
Recruiting
Phase 3
Intravenous Versus Oral Iron for Treating Iron-Deficiency Anemia in Pregnancy
PregnancyIron-Deficiency Anemia
Women and Infants Hospital of Rhode Island300 enrolled8 locationsNCT05462704